Global sales of topical and injectable cosmeceutical products amounted to nearly $31.7 billion in 2011. It is projected to reach nearly $45.6 billion in 2017 from $35 billion in 2012, representing a five-year compound annual growth rate (CAGR) of 5.4% between 2012 and 2017.
This report provides:
Download Report Overview
SCOPE OF REPORT
This report covers recent developments in the global market for cosmeceuticals. A detailed list of commonly used natural and synthetic ingredients provides a background for the presentation of the topical and injectable cosmeceutical products currently available and those that are likely to be introduced in the near future. The study focuses on cosmeceutical products that promise antiaging and overall appearance-enhancing benefits for adults 18 years and over.
At the date of this report, there is no official classification for cosmeceuticals in most countries. These products are essentially a subset of the cosmetics (skin care) segment of the beauty and personal care industry. The structure of the industry, including distinctive regional differences in R&D, marketing and government regulatory requirements are discussed.
Details of recent sales, market drivers and drawbacks, technological advances and patents inform the projections of global and regional sales of cosmeceuticals through 2017. For the purpose of this report, the regional markets are classified as Asia-Pacific, Europe, North America and the rest of the world (ROW). Profiles of major manufacturers of cosmeceuticals are presented in the report.
Rachel Agheyisi is a freelance research analyst for BCC Research. Her professional experience includes more than 20 years in academia and business consulting. She holds a Ph.D. in Economics from McMaster University, Ontario, Canada.